CJC1295 DAC
GHRH analog studied in growth hormone pathway research.
Research Areas
Scientific Background
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH). The DAC modification has been studied for its effects on extending the compound's pharmacokinetic profile.
Areas of Investigation
Laboratory Information
Technical specifications for research settings
This compound is intended for qualified scientific research only. Not for human or veterinary use. Not for diagnostic or therapeutic applications. Researchers must comply with all applicable regulations in their jurisdiction.
Store at -20°C. Reconstituted solutions at 2-8°C.
Lyophilized powder
>97% by HPLC
Soluble in bacteriostatic water
For in vitro endocrine research applications.
Published Literature
Published research has examined CJC-1295 DAC's molecular mechanisms and pharmacokinetic properties.
Regulatory Classification
CJC-1295 is an investigational compound not available for compounding under current FDA regulations. For qualified research purposes only.
Important Research Notice
This information is compiled from scientific literature for educational purposes only. This website does not sell, distribute, or recommend any compounds for human use. All compounds discussed are for qualified research purposes only.